Opinion
Published on 15 Aug 2022
Smart therapies against global pandemics: A potential of short peptides
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.914467
- 2,196 views
- 18 citations
Type at least 3 characters
1,948 articles
Articles
Original Research
Published on 15 Aug 2022
Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.972660
- 2,290 views
- 1 citation
Original Research
Published on 12 Aug 2022
Cost-effectiveness analysis of olaparib as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation in china
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.818579
- 3,805 views
- 4 citations
Review
Published on 11 Aug 2022
Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.944829
- 10,607 views
- 11 citations
Systematic Review
Published on 11 Aug 2022
Licensing of Orphan Medicinal Products—Use of Real-World Data and Other External Data on Efficacy Aspects in Marketing Authorization Applications Concluded at the European Medicines Agency Between 2019 and 2021
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.920336
- 3,484 views
- 7 citations
Original Research
Published on 11 Aug 2022
Bipartite graph search optimization for type II diabetes mellitus Jamu formulation using branch and bound algorithm
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.978741
- 3,600 views
- 1 citation
Original Research
Published on 11 Aug 2022
A machine learning-based risk warning platform for potentially inappropriate prescriptions for elderly patients with cardiovascular disease
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.804566
- 3,159 views
- 8 citations
Original Research
Published on 10 Aug 2022
National trends in the use of oral chemotherapy over 13 years
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.909948
- 7,069 views
- 10 citations
Review
Published on 09 Aug 2022
Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.955648
- 4,728 views
- 12 citations
Original Research
Published on 05 Aug 2022
Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.946351
- 8,540 views
- 11 citations
Review
Published on 04 Aug 2022
Contribution of patient registries to regulatory decision making on rare diseases medicinal products in Europe
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.924648
- 12,456 views
- 18 citations
Original Research
Published on 01 Aug 2022
Relationship Between Linezolid Exposure and the Typical Clinical Laboratory Safety and Bacterial Clearance in Chinese Pediatric Patients
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.926711
- 2,216 views
- 1 citation
Clinical Trial
Published on 22 Jul 2022
Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19—Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.870493
- 2,316 views
- 10 citations
Systematic Review
Published on 22 Jul 2022
Comparison of the efficiency of anti-VEGF drugs intravitreal injections treatment with or without retinal laser photocoagulation for macular edema secondary to retinal vein occlusion: A systematic review and meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.948852
- 2,502 views
- 8 citations
Original Research
Published on 22 Jul 2022
The Cost-Effectiveness of Tislelizumab Plus Chemotherapy for Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.935581
- 4,322 views
- 14 citations
Brief Research Report
Published on 22 Jul 2022
Drug and therapeutics committee interventions in managing irrational drug use and antimicrobial stewardship in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.829408
- 5,413 views
- 5 citations